The survey of GPs, nurse prescribers and pharmacists across the NHS, conducted by weight loss platform Juniper, comes just weeks after NHS England announced the GP rollout of Mounjaro.

The poll revealed that 100% of participants believe additional support services are important alongside a GLP-1 weight loss medication prescription.

In addition, one-third of respondents believe that without wraparound care services -  such as regular check-ins with healthcare professionals, nutritional counselling, psychological support, and tailored exercise programmes - the medication won't be effective.

The research also revealed that 87% believe digital tools could improve the safety and scalability of GLP-1 medication rollouts.

However, barriers to digital uptake include concerns about patient digital literacy or accessibility (38%), data privacy and security (35%), and lack of integration with existing NHS systems (25%).

The survey found that 86% of respondents believe patients are likely to discontinue treatment before achieving their goals without additional support to manage side effects, while 89% think patients are likely to regain weight if they haven't developed healthy eating and exercise habits during treatment.

Clinical lead at Juniper, Kevin Joshua, said: ‘The reality is that many people have already explored every traditional route and are still struggling to access effective, sustainable care.

‘With the NHS facing unprecedented demand, it is more important than ever to broaden access through innovative approaches.'